𝔖 Bobbio Scriptorium
✦   LIBER   ✦

DNA alkylation studies of combined treatment with methylnitrosourea and ethylmethanesulfonate in mice

✍ Scribed by Thomas Platzek; Gerd Bochert

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
28 KB
Volume
20
Category
Article
ISSN
0270-3211

No coin nor oath required. For personal study only.

✦ Synopsis

The interaction of the DNA-alkylating model compounds, ethylmethanesulfonate (EMS) and methylnitrosourea (MNU), was studied in pregnant NMRI mice by measuring DNA adduction in vivo. Previously, large-scale dose-response studies on teratogenicity as well as on DNA modification were performed using these substances. In addition, the risk of low doses in mice was estimated by comparative use of several approaches including molecular dosimetry. The risk was further analysed by combination experiments on teratogenesis with EMS and MNU. This paper describes a further approach with regard to an interaction of these compounds: the formation of DNA adducts was determined using a combined treatment regimen of [(14)C]-labelled MNU and EMS. The mutual influence of EMS and MNU on the DNA alkylation rates was found to be moderate. The dramatic increase in the teratogenic outcome following combined treatment found in previous studies was obviously not due to a massive interaction regarding the initial DNA alkylation rates. It may be explained, however, by the concept of toxic equivalency. Teratogenesis Carcinog. Mutagen. 20:27-34, 2000.

📜 SIMILAR VOLUMES

Tissue-dependent differences in dna meth
Tissue-dependent differences in dna methylation products of mice treated with methyl-labelled methylnitrosourea
✍ Jaroslav V. Frei 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 French ⚖ 488 KB

## Abstract Adult inbred Swiss mice were given a single carcinogenic dose of methyl‐labelled methylnitrosourea in the range of doses which induces thymic lymphomas, lung adenomas and other random malignant tumours. DNA was extracted from pooled bone marrow, spleens, thymuses, kidneys, livers, or lu

DNA damage in brain cells and behavioral
DNA damage in brain cells and behavioral deficits in mice after treatment with high doses of amantadine
✍ Vanessa Kaefer; Juliane Garcia Semedo; Vivian Francília Silva Kahl; Rafael Gomes 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 390 KB

## Abstract Amantadine (AMA) is an uncompetitive antagonist of the __N‐__methyl‐d‐aspartate receptor, with clinical application, acting on treatment of influenza A virus and Parkinson's disease. It has been proposed that AMA can indirectly modulate dopaminergic transmission. In high doses, the cent

Effect of combination treatment with cyc
Effect of combination treatment with cyclophosphamide and isogeneic or allogeneic spleen and bone marrow cells in leukemic (l1210) mice
✍ S. Vadlamudi; M. Padarathsingh; E. Bonmassar; A. Goldin 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 French ⚖ 496 KB

## Abstract Generalized leukemia was observed on day 3 following intra‐peritoneal inoculation of leukemic (L1210) ascites cells in CDF~1~ mice. On day 3 after tumor implantation, residual viable leukemic cells were detected in the peritoneal cavities and spleens of leukemic mice 6 h following treat

Combined therapy of an established, high
Combined therapy of an established, highly aggressive breast cancer in mice with paclitaxel and a unique DNA-based cell vaccine
✍ Amla Chopra; Tae Sung Kim; InSug O-Sullivan; Don Martinez; Edward P. Cohen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 362 KB

## Abstract Here, we describe the enhanced benefits of treating a highly aggressive breast cancer in mice with a combination of paclitaxel and immunization with a unique DNA‐based cell vaccine. An adenocarcinoma was isolated from a spontaneous neoplasm that arose in the mammary gland of a C3H/He mo

Depression of iron uptake into erythrocy
Depression of iron uptake into erythrocytes in mice by treatment with the combined benzene metabolites p-benzoquinone, muconaldehyde and hydroquinone
✍ Robert L. Guy; Peidi Hu; Gisela Witz; Bernard D. Goldstein; Robert Snydert 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB

Using radio-iron uptake into erythrocytes as a measure of hematopoiesis, it was demonstrated that p benzoquinone (BQ) and muconaldehyde (MUC) are potent inhibitors of bone marrow function in female mice. These two benzene metabolites reduced iron uptake at dosages of <5-6 mg kg-'. The combination of

Phase I study of eniluracil and oral 5-f
Phase I study of eniluracil and oral 5-fluorouracil in combination with docetaxel in the treatment of patients with metastatic breast carcinoma
✍ Edgardo Rivera; Vicente Valero; Massimo Cristofanilli; Debra K. Frye; Daniel J. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

## Abstract ## PURPOSE The authors conducted a single‐institution Phase I clinical trial to determine the maximum tolerated doses and to define the toxic effects of oral eniluracil and oral 5‐fluorouracil (5‐FU) combined with docetaxel in patients with metastatic breast carcinoma. ## PATIENTS AND